Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis
Public ClinicalTrials.gov record NCT07362017. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Open Label Study to Investigate the Safety and Efficacy of Ponesimod in the Treatment of Moderate-to-Severe Chronic Plaque Psoriasis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
An open label study to investigate the safety and efficacy of ponesimod in participants with moderate-to-severe chronic plaque psoriasis
Study identification
- NCT ID
- NCT07362017
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 300 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 17, 2026 (Actual)
- Primary completion
- Aug 2028 (Estimated)
- Completion
- Dec 2028 (Estimated)
- Last update posted
- Sep 22, 2026
2026 – 2028
United States locations
- U.S. sites
- 10
- U.S. states
- 9
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Vanda Investigational Site | Glendale | Arizona | 85308 | Recruiting |
| Vanda Investigational Site | Fremont | California | 94538 | Recruiting |
| Vanda Investigational Site | Miami | Florida | 33126 | Recruiting |
| Vanda Investigational Site | Indianapolis | Indiana | 46250 | Recruiting |
| Vanda Investigational Site | Portsmouth | New Hampshire | 03801 | Recruiting |
| Vanda Investigational Site | Rochester | New York | 14623 | Recruiting |
| Vanda Investigational Site | Wilmington | North Carolina | 28405 | Recruiting |
| Vanda Investigational Site | San Antonio | Texas | 78213 | Recruiting |
| Vanda Investigational Site | Webster | Texas | 77598 | Recruiting |
| Vanda Investigational Site | Spokane | Washington | 99202 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07362017, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 22, 2026 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07362017 live on ClinicalTrials.gov.